External Comparison of Ibalizumab in Trials vs. Other Regimens in OPERA
Clinical trial NCT05495204 · COMPLETED
Trial details
- NCT number
- NCT05495204
- Sponsor
- Epividian
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-08-05
- Primary completion
- 2023-02-20
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.